4P Therapeutics |
5AM Ventures |
Accele Biopharma, Inc. |
Achaogen, Inc. |
ADM Diagnostics, LLC |
Affimed Therapeutics AG |
Akron Molecules GmbH |
Alethia Biotherapeutics Inc. |
Alios Biopharma, Inc. |
Alta Partners |
Altheus Therapeutics, Inc. |
Altravax, Inc. |
Ambit Biosciences |
Ambrx Inc. |
America Stem Cell Inc. |
Amgen Inc. |
AM-Pharma B.V. |
Angiochem |
Anthrocell Pty |
Apposite Capital |
Aquilo Capital |
Aquinox Pharmaceuticals, Inc. |
Armour Therapeutics Inc |
Ash Stevens Inc. |
Astellas Pharma Inc. |
Astex Pharmaceuticals, Inc. |
AstraZeneca |
Asuragen, Inc. |
Asymmetry Global Healthcare |
ATEL Ventures |
Athyrium Capital Management |
Atossa Genetics, Inc. |
Auspex Pharmaceuticals, Inc |
AvidBiotics Corp. |
BASF Venture Capital |
Bavarian Nordic, A/S |
Baxter International Inc |
Baxter Ventures |
Bay City Capital |
BayBio |
BDC Capital Healthcare Fund |
BEAT Biotherapeutics Corp. |
Bellicum Pharmaceuticals, Inc. |
Bijan Capital |
BioCrea |
Biodesy LLC |
BioMed Ventures |
BiomedTracker |
Bio-Path Holdings, Inc. |
BioWorld Today |
Blaise Group International |
Boehringer Ingelheim Pharmaceutical, Inc |
Breakout Labs/ Thiel Foundation |
Bristol-Myers Squibb |
Burrage Capital |
Burrill & Company |
Business Development Bank of Canada |
Business Wire |
BVF L.P. |
BWS Financial Inc. |
CanaccordGenuity |
Capital Royalty L.P. |
Catalyst Pharmaceutical Partners |
Cato BioVentures |
Cerecor Inc. |
CertiChem, Inc |
CG Pharmaceuticals, Inc |
Chubb Group of Insurance Companies |
Cipher Pharmaceuticals Inc. |
Clinical Persona, Inc. |
Colo. Inst. for Drug Device & Diag. Dev. |
Conatus Pharmaceuticals |
Confluence Life Sciences, Inc |
Consulate General of Canada |
Contrafect |
Corium International, Inc |
Coyote Pharmaceuticals |
Critical Outcome Technologies Inc. |
Cureduchenne |
Cyclica Therapeutics Inc |
CytomX Therapeutics, Inc. |
Dalton Pharma Services |
Danken Ventures |
Dectiva |
Dentons |
diaDexus, Inc. |
DiaMedica |
Dicerna Pharmaceuticals |
Dillon Capital Strategies |
DiscoveryBioMed, Inc |
Dorset Capital LLC |
EBD Group |
EcoR1 Capital, LLC |
Edison Investment Research |
EGEN, Inc |
EicOsis, LLC |
ELEISON PHARMACEUTICALS LLC |
Eli Lilly and Company |
Elsevier Business Intelligence |
Elusys Therapeutics |
Enso Ventures |
Epirus Biopharmaceuticals, Inc. |
EPISTAT |
Esperion Therapuetics, Inc. |
Evotec International GmbH |
Fate Therapeutics, Inc. |
Fenwick & West LLP |
Five Prime Therapeutics |
Forest Laboratories, Inc. |
FORMA Therapeutics |
Four Oaks Partners |
FPRT Bio |
Franklin Templeton Investments |
Frazier Healthcare Ventures |
GE capital |
Gemmus Pharma Inc. |
GeneCentric Diagnostics, Inc |
Genenews |
GenSpera, Inc. |
Georgia State University Research Foundation |
GlobeImmune, Inc. |
GLYCOMIMETICS, INC. |
Greenwich LifeSciences |
Halsa Pharmaceuticals |
Healthy Living Magazine |
Heat Biologics |
Helix Ventures |
HepSeeVax |
Hightech Reports |
Horizon Pharma |
Hua Medicine |
Igenica, Inc |
immatics biotechnologies GmbH |
Immune Design |
IMMUNE Pharmaceuticals Inc |
Immunovaccine |
INanoBio |
Innotrove LLC |
Innovus Pharmaceuticals, Inc. |
inovation ventures |
Inovio Pharmaceuticals |
InSymbiosis |
Integrium |
International Finance Corporation |
International Stem Cell Corporation |
Inventis Investment Holdings (China) Ltd |
Investor Growth Capital |
IPF Partners |
Jade Therapeutics, Inc. |
Janssen Pharmaceutical Companies of John |
Jennerex, Inc. |
Johnson & Johnson |
JT Pharma |
Kala Pharmaceuticals |
KangLaiTe USA Inc |
Karolinska Development AB (publ.) |
Kearny Venture Partners |
KineMed, Inc |
Kissei America, Inc |
KMA & Company |
Knobbe Martens Olson & Bear LLP |
Knoll Capital Management LLC |
KPCB |
KVP |
La Jolla Pharmaceutical Company |
Labrys Biologics, Inc. |
Latterell Venture Partners |
Leading Biosciences, Inc. |
Life Science Angels |
Life Science Leader |
Lion Biotechnologies |
Livwel Therapeutics Inc |
Longitude Captial |
Lumira Capital |
MabVax Therapeutics, Inc. |
Mast Therapeutics, Inc. |
Maverix Biomics, Inc. |
MAX BioPharma Inc. |
MaxCyte |
Medical Technology Stock Letter |
MedPanel Capital Advisors |
Menogenix, Inc. |
Mercadyne Investments, LLC |
Merck |
Mercury Fund |
Mergermarket |
Microbiotix, Inc. |
Milestone Capital |
Mirna Therapeutics, Inc |
Mission Bay Capital |
Mitsubishi Corporation |
Mizuho Securities USA |
Mochida Pharmaceutical |
Momenta Pharmaceuticals, Inc. |
Morgan Lewis & Bockius LLP |
Morphochem AG |
MP Healthcare Venture Management, Inc. |
MPM Capital |
Muse Capital |
MustangVC |
MyeloRx LLC |
Nano3D Biosciences, Inc. |
Nanofiber Solutions |
NEA |
NeoStem |
Neuraltus Pharmaceuticals, Inc. |
New Biology Ventures, LLC |
New Enterprise Associates |
NEWGEN THERAPEUTICS, INC. |
Next Big Thing Investor.com |
NGN Capital LLC |
NLV |
NLVP |
NOVARTIS |
Novartis Venture Fund |
NovelMed Therapeutics, Inc. |
Numab AG |
Numoda Capital Innovations |
Ocera Therapeutics, Inc |
OncologyLink news-n-notes |
OncoMed Pharmaceuticals, Inc. |
OncoSec Medical |
Ontario Government |
Onyx Pharmaceuticals |
Opsona Therapeutics Ltd. |
Opus Point Partners |
Orange County Research Center |
OrbiMed Advisors |
Oxford Bioscience Partners |
Oxigene |
OxThera AB |
Palatin Technologies, Inc. |
Palo Alto Investors |
Parabon NanoLabs |
ParinGenix, Inc. |
Patrys Limited |
Piper Jaffray & Co |
Poliwogg |
Polynoma |
PreScience Labs |
Principia Biopharma |
Probiodrug AG |
Protagonist Therapeutics Inc. |
Proteon Therapeutics, Inc. |
Purdue Pharma LP |
Quest PharmaTech Inc |
Questcor Pharmaceuticals, Inc |
QVT |
Radius Health, Inc |
RECARDIO |
Regado Biosciences, Inc. |
Resverlogix |
ROTH Capital Partners |
Russo Partners |
RXi Pharmaceuticals |
S1 Biopharma |
S1 Biopharma, Inc. |
Sagient Research |
San Diego Tech Coast Angels |
San Francisco Business Times |
SantA Ventures |
ScarX Therapeutics |
scendiant |
Science Futures |
Scrip Intelligence |
Sensorion |
Sernova Corp |
Shinyusha Publishing |
Sialix |
Sirona Biochem |
SironRX Therapeutics, Inc. |
Slater Technology Fund |
Sofinnova Ventures |
Sophiris Bio, Corp |
Spring Bank Pharmaceuticals |
SR One, Limited |
Stemina Biomarker Discovery |
Stiftelsen Industrifonden |
Strategy Signal LLC |
Sutro Biopharma, Inc |
SVB |
Syndax Pharmaceuticals, Inc. |
Syzygy Therapeutics |
Tavistock Group |
Tech Coast Angels |
TeraDiscoveries, Inc |
The Burrill Report |
The Conafay Group |
The Life Sciences Report |
The Scripps Research Institute |
The Trout Group LLC |
Theraclone Sciences, Inc |
TherapeuticsMD.com |
TheraVasc Inc. |
Third Rock Ventures |
Thorner Ventures |
three arch |
TissueGene, Inc. |
Topica Pharmaceuticals, Inc. |
TriplePoint Capital |
Tymora Analytical Operations |
Tynan Consulting |
UCSF |
US Venture Partners |
Vaccinex |
Valence Life Sciences |
Vascular Pharmaceuticals |
Versant Ventures |
Versartis, Inc. |
viDA Therapeutics Inc |
Viking Therapeutics, Inc. |
Visionary Pharmaceuticals |
Vista Partners LLC |
Vivaldi Biosciences Inc. |
Vivo Ventures |
VWR International, LLC |
Wall Street Journal |
WCG |
William Harris Investors |
WRF Capital |
www.carmot.us |
Xalud Therapeutics, Inc. |
Zafgen |
ZIOPHARM Oncology, Inc |
Zymeworks Inc. |